RNA结合蛋白ZCCHC24促进了三阴性乳腺癌的瘤性
Yutaro Uchida1, Ryota Kurimoto1, Tomoki Chiba1
1Department of Systems Biomedicine, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
EMBO reports
|October 17, 2024
概括
向ZCCHC24,一种RNA结合蛋白,在三阴性乳腺癌 (TNBC) 中显示出治疗潜力. 降低ZCCHC24水平可以对抗TNBC模型中的治疗耐药性和瘤生长.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 癌症干细胞研究研究
背景情况:
- 三阴性乳腺癌 (TNBC) 是具有侵略性的,缺乏有效的治疗点.
- 癌症干细胞 (CSCs) 驱动TNBC治疗耐药性和患者的不良结果.
- 准CSC对于改善TNBC患者存活率至关重要.
研究的目的:
- 在TNBC CSC人群中确定新的治疗点.
- 研究RNA结合蛋白ZCCHC24在TNBC瘤性和治疗耐药性中的作用.
主要方法:
- 鉴定中细胞样TNBC细胞中ZCCHC24丰富的情况.
- 对ZCCHC24与mRNA cis元素 (UGUWHWWA) 的直接结合进行分析,以稳定目标基因.
- 在TNBC患者衍生异种移植 (PDX) 中使用siRNAs评估ZCCHC24的淘汰效应.
- 在TNBC PDXs中对联合ZCCHC24倒置和BET抑制剂JQ1疗法的评估.
主要成果:
- 通过稳定特定的mRNAs,ZCCHC24促进瘤性和治疗耐药性.
- ZCCHC24直接与UGUWHWWA元素结合,稳定关键基因的mRNA,包括ZEB1.1.
- 作为ZCCHC24的标,ZEB1增强了癌症干性,并相互诱导了ZCCHC24的表达.
- ZCCHC24 Knockdown 降低了中介细胞样细胞群,并在TNBC PDXs中表现出治疗效果.
- 结合ZCCHC24淘汰和JQ1治疗协同抑制了TNBC PDXs中的瘤生长.
结论:
- 通过调节CSC相关基因表达,ZCCHC24是TNBC攻击性和治疗耐药性的关键驱动因素.
- 准ZCCHC24代表了TNBC的一个有前途的治疗策略.
- 涉及ZCCHC24抑制和BET抑制剂的组合疗法可以克服TNBC中的治疗抵抗.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K


